
Sign up to save your podcasts
Or
Dexmedetomidine — or “Dex” — has become one of the most intriguing and versatile drugs in the anesthesia world. In this episode of Anesthesia Alchemy with hosts Lynn Macksey, MSN, CRNA and Garry Brydges, PhD, DNP, MBA, CRNA, ACNP-BC, FAAN dive deep into the pharmacology, clinical application, and emerging research surrounding this alpha-2 agonist.
Here’s some of what we discuss in this episode:
🧠 CNS receptor action and sedative pathways
Visit us online: https://beyondthemaskpodcast.com/
The 1099 CRNA Institute: https://aana.com/1099
Get the CE Certificate here (and directly submit to the NBCRNA): https://beyondthemaskpodcast.com/wp-content/uploads/2020/04/Beyond-the-Mask-CE-Cert-FILLABLE.pdf
Help us grow by leaving a review: https://podcasts.apple.com/us/podcast/beyond-the-mask-innovation-opportunities-for-crnas/id1440309246
4.7
190190 ratings
Dexmedetomidine — or “Dex” — has become one of the most intriguing and versatile drugs in the anesthesia world. In this episode of Anesthesia Alchemy with hosts Lynn Macksey, MSN, CRNA and Garry Brydges, PhD, DNP, MBA, CRNA, ACNP-BC, FAAN dive deep into the pharmacology, clinical application, and emerging research surrounding this alpha-2 agonist.
Here’s some of what we discuss in this episode:
🧠 CNS receptor action and sedative pathways
Visit us online: https://beyondthemaskpodcast.com/
The 1099 CRNA Institute: https://aana.com/1099
Get the CE Certificate here (and directly submit to the NBCRNA): https://beyondthemaskpodcast.com/wp-content/uploads/2020/04/Beyond-the-Mask-CE-Cert-FILLABLE.pdf
Help us grow by leaving a review: https://podcasts.apple.com/us/podcast/beyond-the-mask-innovation-opportunities-for-crnas/id1440309246
1,871 Listeners
1,475 Listeners
30,247 Listeners
2,422 Listeners
739 Listeners
380 Listeners
218 Listeners
287 Listeners
189 Listeners
108 Listeners
1,633 Listeners
3,358 Listeners
17 Listeners
33 Listeners
122 Listeners